Human Genome Epidemiology Literature Finder
Records 1 - 23 (of 23 Records) |
Query Trace: Disease Progression and ATM[original query] |
---|
Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Haematologica 2002 1 87 (1): 44-51. Cuneo Antonio, Bigoni Renato, Rigolin Gian Matteo, Roberti Maria Grazia, Bardi Antonella, Cavazzini Francesco, Milani Raffaella, Minotto Claudia, Tieghi Alessia, Della Porta Matteo, Agostini Paola, Tammiso Elisa, Negrini Massimo, Castoldi Gianlui |
Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children. Genes, chromosomes & cancer 2003 12 39 (2): 161-6. Liberzon Ella, Avigad Smadar, Stark Batia, Zilberstein Julia, Freedman Laurence, Gorfine Malka, Gavriel Herzel, Cohen Ian J, Goshen Yacov, Yaniv Isaac, Zaizov Ri |
ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele. Haematologica 2012 Jan 97 (1): 142-6. Skowronska Anna, Austen Belinda, Powell Judith E, Weston Victoria, Oscier David G, Dyer Martin J S, Matutes Estella, Pratt Guy, Fegan Christopher, Moss Paul, Taylor Malcolm A, Stankovic Tatja |
Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
ARID1B alterations identify aggressive tumors in neuroblastoma. Oncotarget 2017 Jul 8 (28): 45943-45950. Lee Soo Hyun, Kim Jung-Sun, Zheng Siyuan, Huse Jason T, Bae Joon Seol, Lee Ji Won, Yoo Keon Hee, Koo Hong Hoe, Kyung Sungkyu, Park Woong-Yang, Sung Ki |
Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Oct . Zilberg Catherine, Lee Matthew Weicai, Yu Bing, Ashford Bruce, Kraitsek Spiridoula, Ranson Marie, Shannon Kerwin, Cowley Mark, Iyer N Gopalakrishna, Palme Carsten E, Ch'ng Sydney, Low Tsu-Hui Hubert, O'Toole Sandra, Clark Jonathan R, Gupta Ru |
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Jan . Jonasch E, Hasanov E, Corn P G, Moss T, Shaw K R, Stovall S, Marcott V, Gan B, Bird S, Wang X, Do K A, Altamirano P F, Zurita A J, Doyle L A, Lara P N, Tannir N |
Detection of circulating tumour cell clusters in human glioblastoma. British journal of cancer 2018 8 119 (4): 487-491. Krol Ilona, Castro-Giner Francesc, Maurer Martina, Gkountela Sofia, Szczerba Barbara Maria, Scherrer Ramona, Coleman Niamh, Carreira Suzanne, Bachmann Felix, Anderson Stephanie, Engelhardt Marc, Lane Heidi, Evans Thomas Ronald Jeffry, Plummer Ruth, Kristeleit Rebecca, Lopez Juanita, Aceto Nico |
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia 2018 7 33 (2): 390-402. Leeksma Alexander C, Taylor Justin, Wu Bian, Gardner Jeffrey R, He Jie, Nahas Michelle, Gonen Mithat, Alemayehu Wendimagegn G, Te Raa Doreen, Walther Tatjana, Hüllein Jennifer, Dietrich Sascha, Claus Rainer, de Boer Fransien, de Heer Koen, Dubois Julie, Dampmann Maria, Dürig Jan, van Oers Marinus H J, Geisler Christian H, Eldering Eric, Levine Ross L, Miller Vincent, Mughal Tariq, Lamanna Nicole, Frattini Mark G, Heaney Mark L, Zelenetz Andrew, Zenz Thorsten, Abdel-Wahab Omar, Kater Arnon |
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 7 14 (11): 1924-1934. Goeman Frauke, De Nicola Francesca, Scalera Stefano, Sperati Francesca, Gallo Enzo, Ciuffreda Ludovica, Pallocca Matteo, Pizzuti Laura, Krasniqi Eriseld, Barchiesi Giacomo, Vici Patrizia, Barba Maddalena, Buglioni Simonetta, Casini Beatrice, Visca Paolo, Pescarmona Edoardo, Mazzotta Marco, De Maria Ruggero, Fanciulli Maurizio, Ciliberto Gennaro, Maugeri-Saccà Marcel |
ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data. Radiation oncology (London, England) 2020 Jul 15 (1): 184. Kim Nalee, Kim Se Hoon, Kang Seok-Gu, Moon Ju Hyung, Cho Jaeho, Suh Chang-Ok, In Yoon Hong, Chang Jong H |
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 5 38 (21): 2380-2389. Bustoros Mark, Sklavenitis-Pistofidis Romanos, Park Jihye, Redd Robert, Zhitomirsky Benny, Dunford Andrew J, Salem Karma, Tai Yu-Tzu, Anand Shankara, Mouhieddine Tarek H, Chavda Selina J, Boehner Cody, Elagina Liudmila, Neuse Carl Jannes, Cha Justin, Rahmat Mahshid, Taylor-Weiner Amaro, Van Allen Eliezer, Kumar Shaji, Kastritis Efstathis, Leshchiner Ignaty, Morgan Elizabeth A, Laubach Jacob, Casneuf Tineke, Richardson Paul, Munshi Nikhil C, Anderson Kenneth C, Trippa Lorenzo, Aguet François, Stewart Chip, Dimopoulos Meletios-Athanasios, Yong Kwee, Bergsagel P Leif, Manier Salomon, Getz Gad, Ghobrial Irene |
Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Journal of clinical and translational research 2021 7 7 (3): 386-413. Yang Zhao, Shen Zongyi, Jin Di, Zhang Nan, Wang Yue, Lei Wanjun, Zhang Zhiming, Chen Haige, Naz Faiza, Xu Lida, Wang Lei, Wang Shihui, Su Xin, Yu Changyuan, Li Cho |
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib. Journal of experimental & clinical cancer research : CR 2021 6 40 (1): 215. Fujii Yasutoshi, Ono Atsushi, Hayes C Nelson, Aikata Hiroshi, Yamauchi Masami, Uchikawa Shinsuke, Kodama Kenichiro, Teraoka Yuji, Fujino Hatsue, Nakahara Takashi, Murakami Eisuke, Miki Daiki, Okamoto Wataru, Kawaoka Tomokazu, Tsuge Masataka, Imamura Michio, Chayama Kazua |
Enhancing the landscape of colorectal cancer using targeted deep sequencing. Scientific reports 2021 Apr 11 (1): 8154. Lee Chul Seung, Song In Hye, Lee Ahwon, Kang Jun, Lee Yoon Suk, Lee In Kyu, Song Young Soo, Lee Sung H |
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations. Current oncology (Toronto, Ont.) 2022 4 29 (4): 2776-2791. Neviere Zoé, Coquan Elodie, Brachet Pierre-Emmanuel, Meriaux Emeline, Bonnet Isabelle, Krieger Sophie, Castéra Laurent, Vaur Dominique, Boulouard Flavie, Leconte Alexandra, Lequesne Justine, Lelaidier Anais, Ricou Agathe, Joly Floren |
The Genomic Landscape of Colorectal Cancer in the Saudi Arabian Population Using a Comprehensive Genomic Panel. Diagnostics (Basel, Switzerland) 2023 9 13 (18): . Ebtehal Alsolme, Saleh Alqahtani, Musa Fageeh, Duna Barakeh, Nitesh K Sharma, Serghei Mangul, Heather A Robinson, Amany Fathaddin, Charlotte A E Hauser, Malak Abedalthaga |
Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2?+?metastatic breast cancer. Scientific reports 2023 6 13 (1): 9928. Kyoungmin Lee, Jongwon Lee, Jungmin Choi, Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, In Hae Pa |
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 100150. Dogan Snjezana, Xu Bin, Rana Satshil, Chen Hui, Ghossein Ronald A, Berger Michael F, Ho Alan L, Katabi No |
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 11 JCO2300339. Joaquin Mateo, Johann S de Bono, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Mustafa Özgüro?lu, Niven Mehra, Nobuaki Matsubara, Jae Young Joung, Charles Padua, Ernesto Korbenfeld, Jinyu Kang, Helen Marshall, Zhongwu Lai, Alan Barnicle, Christian Poehlein, Natalia Lukashchuk, Maha Hussa |
DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients. Cancers 2023 10 15 (20): . Dorota Butkiewicz, Ma?gorzata Krze?niak, Agnieszka Gdowicz-K?osok, Krzysztof Sk?adowski, Tomasz Rutkows |
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO open 2023 10 8 (6): 102041. S Joris, H Denys, J Collignon, M Rasschaert, D T'Kint de Roodenbeke, F P Duhoux, J-L Canon, S Tejpar, J Mebis, L Decoster, P Aftimos, J De Grè |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: